Prot #CA209-77T: A Phase 3, Randomized, Double-blind Study of Neoadjuvant Chemotherapy plus Nivolumab versus Neoadjuvant Chemotherapy plus Placebo, followed by Surgical Resection and Adjuvant Treatment with Nivolumab or Placebo for Participants with Resec

  • Patel, Jyoti D (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date8/6/208/6/23

Funding

  • Bristol-Myers Squibb Company (Prot #CA209-77T)